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The gene encoding yeast phosphoglycerate mutase was isolated, and its sequence was determined. The gene specifies a
protein of 246 amino acids, and contains no introns. The sequence shows a strong codon bias. The upstream untranslated 
portion of the gene contains a CT-rich block such as is found in many highly expressed yeast genes, but does not have 
the associated CAAG sequence. 
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1. INTRODUCTION 
Phosphoglycerate mutases comprise a family of 
enzymes which catalyse reactions involving the 
transfer of phospho groups among the three car- 
bon atoms of phosphoglycerates. There are at least 
five types of phosphoglycerate mutase that are 
kinetically and structurally distinct, but never- 
theless have many features in common (e.g. see 
[l--31). The enzyme from Succhuromyces 
cerevisiae has been extensively characterized, and 
the high-resolution crystallographic structure and 
amino acid sequence have been reported [4,5]. We 
present here the isolation and sequence determina- 
tion of the gene encoding this enzyme, as a prere- 
quisite for protein engineering studies to 
investigate its mode of action. 
2. EXPERIMENTAL 
The gene encoding S. cerevisiae phosphoglycerate mutase 
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The nucleotide sequence presented here has been submitted to 
the EMBLKenBank database under the accession number 
X06408 
(GPM) has been obtained in the multicopy plasmid YEpl3 by 
complementation [6], and was kindly given to us by D.G. 
Fraenkel. A restriction map of the plasmid was constructed, 
and the coding sequence was located with the use of 
oligonucleotide probes. A HindIII/WI restriction fragment 
containing the entire coding region together with several hun- 
dred base pairs of flanking sequences was subcloned into phage 
Ml3 for sequence determination by the dideoxy method. The 
use of the Sequenase DNA sequencing kit (US Biochemical 
Corp., Cleveland, OH) allowed sequences of about 500 bases to 
be determined from a single primer. 
3. RESULTS AND DISCUSSION 
3.1. Restriction mapping of YEpl3-GPM 
Restriction mapping of the recombinant YEpl3 
plasmid revealed an insert of 6 kbp of S. cerevisiae 
chromosomal DNA (fig. 1). The phosphoglycerate 
mutase coding sequence was located within this in- 
sert by Southern blotting with two end-labelled 
oligonucleotides corresponding to the N- and C- 
terminal regions of the protein sequence. Both 
oligonucleotides hybridized specifically to a 
1.3 kbp HindIII/Safl restriction fragment which 
was therefore subcloned into phage M13mp19 for 
sequencing. 
3.2.‘ Nucleotide sequence of GPA4 gene 
The strategy used to sequence the 
phosphoglycerate mutase gene is summarised in 
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fig. 1. A contiguous stretch of 1154 bases was se- 
quenced which includes an open reading frame of 
741 bases encoding the enzyme phosphoglycerate 
mutase (fig.2). The DNA sequence largely agrees 
with the previously determined protein sequence, 
and the differences are discussed below. 
Phosphoglycerate mutase is typical of glycolytic 
enzymes in yeast in being highly expressed. Like 
other highly expressed yeast genes [7], GPM ex- 
hibits an extreme codon bias. Only 31 codons are 
used, and of these 24 account for 93% of the 
amino acids (phosphoglycerate mutase has no cys- 
teine residues). This compares with values of 94% 
for phosphoglycerate kinase, 95% for enolase I 
and 95% for alcohol dehydrogenase I. The 
upstream flanking sequence also has features 
similar to those of other highly expressed yeast 
genes. These include A residues at - 1 and - 3, 
and a 44 base A-rich region containing no G 
residues immediately adjacent to the initiating 
ATG codon [8]. Another feature found in many 
highly expressed yeast genes is a CT-rich block, 
here present at - 83 to - 109, but there is no 
associated CAAG sequence 191. A TATA box at 
position - 138 may be involved in the initiation of 
transcription, and the sequence CACACA at posi- 
tion - 16 is found in several other yeast genes 
although its function is not known [9]. The 
downstream flanking region is AT-rich (73%), and 
contains two possible polyadenylation/transcrip- 
tion termination signals TAG. . . TAGT . . . TTT at 
positions 812 and 844 [lo]. 
3.3. Comparison of DNA and protein sequences 
A comparison of the amino acid sequence 
deduced from the DNA sequence with that deter- 
mined by manual Edman degradation of pro- 
teolytic fragments of the protein [5] reveals several 
discrepancies (fig.2). Some of the differences 
probably relate to S. cerevisiae strain differences. 
The phosphoglycerate mutase used for the protein 
sequencing and X-ray crystallography was purified 
from dried baker’s yeast, and was genetically 
heterogeneous as indicated by sequence micro- 
heterogeneities between residues 139 and 166 [5]. 
The sequence differences between residues 46 and 
52 may indicate an additional heterogeneous 
region. The occurrence of sequence heterogeneities 
complicated the protein sequence determinations, 
and was the reason for wrongly assigning the posi- 
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Fig.1. Restriction map of YEpl3-GPM and sequencing strategy 
of GPM gene. The thick lines indicate the phosphoglycerate 
mutase coding sequence. Arrows show the direction and length 
of individual sequence determinations. Restriction enzymes: 
Hind111 (H), WI (S), EcoRI (E), Bg/II (B), &~nH1 (Ba), XhoI 
(X) and A/u1 (A). 
tion of the Asp-Leu sequence (residues 169-170). 
The other sequence discrepancies can be explained 
in terms of difficulties inherent in the manual Ed- 
man degradation procedure. For example, the 
amide assignments were largely based on the elec- 
trophoretic mobilities of peptides, and residue 99 
was incorrectly assigned as glutamine because of 
the abnormally low pK of His-88. The interchange 
of the serine and valine residues at positions 172 
and 176 resulted from having missed the labile 
serine residue after Edman degradation. Similarly, 
the sequence between residues 207 and 210 involves 
an incompletely cleaved proline and a labile 
threonine. The determination of the sequence of 
the C-terminal portion of the protein relied heavily 
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22s TGGCIT;CCAGTCCICIC&TCCTGGAbTTGMC G~~cATTcIc&~T~TTA&GGT 
7s WIPVNRSWR,LNERHYGDLQG 
285 AAGG&CIAGGCTGAt&TTTGMbGAkTTCGGTG@&i#tMTTC~RCCT~ 
9s K DKAETLKKFGEEKFNTYRR 
345 
115 
. . 
TCCTTkTGTTCCACCTCCCICCACI;COCICOCTTCTTCTCC~TTCkT ~T~IAT 
SFDVPPPPIDASSPFSQKGD 
2G4 
94 
344 
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4Q4 
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40s G~GiTCICAAGTA~TTGACCC&GTCTTGCC’ CIOACVICTGhAkTTTGGCTTkGTC 464 
13s ERYKYVDPNVLPETESLALV IS4 
465 
15s 
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17s 
ATTGAkATTGTT&CAThCTGGC&G~TGTCAT&CC MGG%;TGTTGI%~TG~TMG 
IDRLLPYWQDVIAKDLLSGK 
_ _ V 
ACCGT~ATGATCGCC;ICTC&CGGTAkTCClTGhGiGGTTTGGTTkCACTTGGkGGT 
TVI’lIAfiHGNSLRGLVKHLEG 
S 
384 
194 
Se5 
19s 
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215 
P T I 
TTGGA;GAAMCTTGkCCATCTAiGCCATCTT~~TACTTGGf&CMtMGC * TGCCGCT 
LDENLKPSKPSYYLDPEAflfi 
704 
234 
70s 
235 
764 
246 
765 
825 
885 
. . 
GCTGG~GCCGCTGCTbTTGCCAXCMGGTAAGhA~TAAGTCTGh~TGhATGiTTTG 
fiGAfl&VANQGKK 
K G 
~TGCIT;TCTTTTTCC~TCCCITTTTT~TTCICT~T~T~TC~T~~~T~CTTG~~T~ 
XTTnT;nUICnnnT;nnaTCT~~~T~~C~T~GTT~GT~~TT~ 
824 
. 
GCITTaTTCGTCGAC G9G 
Fig.2. Nucleotide sequence and deduced amino acid sequence of GPM gene. The underlined sequences are discussed in the text. 
Residues different in the published protein sequence [S] are indicated below the deduced amino acid sequence, and are discussed in 
the text. 
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on overlapping peptic peptides, and the unusually 
large number of alanines between residues 232 and 
239 (7 of 8 residues) was incorrectly identified. The 
presence of a glutamine at position 243 reduced the 
efficiency of Edman degradation, and the order of 
the C-terminal three residues was largely assigned 
on the basis of the complete resistance of this 
region to digestion by carboxypeptidases A, B and 
Y. 
3.4. Comparison with mammalian phospho- 
glycerate mutases 
Phosphoglycerate mutase exists as three dif- 
ferent isoenzymes in mammalian tissues: type M 
Y 
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mm 
mm 
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m 
nK 
UK 
3 0 40 50 
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Fig.3. Comparison of amino acid sequences of yeast and mammalian phosphoglycerate mutases. The sequences are taken from the 
following references: human muscle phosphoglycerate mutase (HM) [14], human erythrocyte phosphoglycerate mutase (HE) [15], 
rabbit erythrocyte phosphoglycerate mutase (RE) [16] and fructose 2,bbisphosphatase (FP) [13]. The numbering along the top of the 
sequences refers to the yeast sequence, and that below to the erythrocyte sequences. The boxed-in residues how the regions that are 
identical in three or more sequences. Gaps have been introduced in the Y and HM sequences to maximise homology. 
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predominates in muscle, type B in brain and type 
E in erythrocytes. The E type enzyme catalyses the 
synthesis and breakdown of 2,3-bisphospho- 
glycerate (2,3-BPG), in addition to catalysing the 
interconversion of 2- and 3-phosphoglycerates. 
This isoenzyme is frequently known as bisphos- 
phoglycerate mutase, and plays a major role in 
regulating haemoglobin oxygen affinity as a conse- 
quence of controlling 2,3-BPG concentration. A 
comparison of the sequence of yeast phospho- 
glycerate mutase with the sequences of M and E 
type mammalian phosphoglycerate mutases is 
given in fig.3. These enzymes show the same slow 
rate of evolution as observed for other glycolytic 
enzymes [111, with about half of the residues iden- 
tical between the yeast and mammalian enzymes. 
The two mammalian isoenzymes are as divergent 
from each other (49% different) as they are from 
the yeast enzyme, implying that the E isoenzyme 
experienced aperiod of rapid change after the gene 
duplication of an ancestral mutase gene before it 
settled down to the slow rate of change shown by 
a comparison of the rabbit and human E isoen- 
zymes (3.5% different). 
Most, but not all, of the active-site residues [4] 
are conserved. Thus, His-8 (yeast numbering) and 
His-181 which are involved in phospho transfer 
and Arg-59 which is required for binding the car- 
boxy1 group of the phosphoglycerates are identical 
in all sequences. However, Ser-11 and Thr-20 
which in the yeast enzyme probably provide 
ligands for binding the transferred phospho group 
are not conserved. The replacement of Ser-1 1 by a 
glycine in the E isoenzyme is consistent with the 
greater instability of its phosphorylated form [12], 
and also with the relative ease with which the 
product 2,3-BPG can dissociate [l]. The replace- 
ment of Thr-20 by a cysteine explains why muscle 
but not yeast phosphoglycerate mutase is inhibited 
by thiol modifying reagents (review [ 111). 
The sequence of an active-site peptide from rat 
liver fructose 2,6_bisphosphatase has recently been 
reported, and its homology with the active site of 
phosphoglycerate mutases noted [13] (see fig.3). 
Like the mutases, fructose 2,6_bisphosphatase in- 
volves a phosphohistidine intermediate (His-8 of 
the yeast mutase), and the sequence similarities in- 
dicate that the enzymes have probably diverged 
from a common ancestor. 
Acknowledgements: We are particularly grateful to Dr D.G. 
Fraenkel for the gift of the YEpl3GPM plasmid. We thank the 
Science and Engineering Research Council for financial sup- 
port, and the Wellcome Trust for funding the OSWEL 
oligonucleotide synthesis facility. L.A.F.G. is the recipient of 
a Wellcome Trust University Award. 
REFERENCES 
111 
121 
[31 
141 
PI 
161 
[71 
Fl 
191 
WI 
1111 
WI 
v31 
1141 
WI 
WI 
Rose, Z.B. (1980) Adv. Enzymol. Relat. Areas Mol. Biol. 
51, 211-253. 
Oh, Y.K. and Freeze, B. (1976) J. Bacterial. 127, 
739-746. 
Price, N.C., Duncan, D. and Ogg, D.J. (1985) Int. J. 
Biochem. 17, 843-846. 
Winn, S.I., Watson, H.C., Harkins, R.N. and Fothergill, 
L.A. (1981) Phil. Trans. R. Sot. Lond. B 293, 121-130. 
Fothergill, L.A. and Harkins, R.N. (1982) Proc. R. Sot. 
Lond. B 215, 19-44. 
Kawasaki, G. and Fraenkel, D.G. (1982) Biochem. Bio- 
phys. Res. Commun. 108, 1107-1112. 
Benetzen, J.L. and Hall, B.D. (1982) J. Biol. Chem. 257, 
3026-303 1. 
Hamilton, R., Watanabe, C. and De Boer, H.A. (1987) 
Nucleic Acids Res. 15, 3581-3593. 
Dobson, M.J., Tuite, M.F., Roberts, N.A., Kingsman, 
A. J., Kingsman, S.M., Perkins, R.E., Conroy, S.C., 
Dunbar, B. and Fothergill, L.A. (1982) Nucleic Acids 
Res. 10, 2625-2637. 
Zaret, K.S. and Sherman, F. (1982) Cell 28, 563-573. 
Fothergill-Gilmore, L.A. (1986) Trends Biochem. Sci. 11, 
47-51. 
Han, C.-H. and Rose, Z.B. (1979) J. Biol. Chem. 254, 
8836-8840. 
Pilkis, S.J., Lively, M.O. and El-Maghrabi, M.R. (1987) 
J. Biol. Chem. 262, 12672-12675. 
Shanske, S., Sakoda, S., Hermodson, M.A., DiMauro, S. 
and Schon, E.A. (1987) J. Biol. Chem. 262,14612-14617. 
Joulin, V., Peduxxi, J., Romeo, P.-H., Rosa, R., 
Valentin, C., Dubart, A., Lapeyre, B., Blouquit, Y., 
Garel, M.-C., Gooseens, M., Rosa, J. and Cohen-Solal, 
M. (1986) EMBO J. 5, 2275-2283. 
Yanagawa, S., Hitomi, K., Sasaki, R. and Chiba, H. 
(1986) Gene 4, 185-191. 
387 
